Psychosocial Adaptation, SCHIZOPHRENIA 1 (Disorder), Treatment Adherence
Conditions
Keywords
treatment adherence, Schizophrenia, solution-focused therapy,, psychiatric nursing
Brief summary
The aim of this study is to evaluate the effects of a solution-focused approach-based individual intervention on psychosocial adjustment and treatment adherence in individuals diagnosed with schizophrenia. The study will be conducted as a randomized controlled trial including 60 clinically stable individuals diagnosed with schizophrenia according to DSM-5 criteria and registered at a Community Mental Health Center affiliated with a university hospital. Participants will be randomly assigned to an experimental group (n=30) and a control group (n=30). The experimental group will receive one individual solution-focused therapy session per week for six weeks. The control group will receive usual care only. Data will be collected using a Personal Information Form, the Psychosocial Adjustment Scale (PSSAS), and the Medication Adherence Scale (MARS).
Detailed description
Objective: Schizophrenia is a chronic psychiatric disorder that significantly affects thought, emotion, and behavior, often limiting social functioning, treatment adherence, and integration into daily life. There is an increasing need for person-centered, empowering, and brief intervention models in psychiatric nursing. This study aims to determine the effects of a solution-focused approach (SFA)-based individual intervention on psychosocial adjustment and treatment adherence in individuals with schizophrenia. Study Design: This research will use a pretest-posttest randomized controlled experimental design with a control group. Study Population: The study will include 60 individuals diagnosed with schizophrenia according to DSM-5 diagnostic criteria, considered clinically stable, and registered at a Community Mental Health Center affiliated with a university hospital in Türkiye. Participants will be randomly assigned to an experimental group (n=30) or a control group (n=30) using computer-assisted randomization. Intervention: Experimental Group: Participants will receive individual solution-focused therapy sessions once per week for six consecutive weeks. The sessions will emphasize individual strengths, recall positive coping experiences, support future goal setting, and provide guidance on repeating effective solutions. Control Group: Participants will receive no additional intervention beyond usual care. Outcome Measures: Data will be collected with the following instruments: Personal Information Form Psychosocial Adjustment Scale (PSSAS) Medication Adherence Scale (MARS) Statistical Analyses: Planned analyses will include independent samples t-tests, paired t-tests, and ANCOVA.
Interventions
BEHAVIORALsolution-oriented approach program
The solution-focused nursing intervention applied to the experimental group in the study was planned as individual sessions, consisting of one session per week, lasting a total of six weeks. The interventions were based on the principles of solution-focused brief therapy, focusing on the individual's strengths, past coping experiences, and current resources. The interviews aimed to identify exceptions, build positive future expectations, set small but achievable goals, strengthen hope, and increase the individual's ability to utilize their internal resources. Each session used structured open-ended questions, scaling techniques, and future-oriented solution scenarios to support the individual's psychosocial adjustment and motivation for treatment.
Sponsors
Muş Alparslan University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Having been diagnosed with schizophrenia according to DSM-5 diagnostic criteria, Being between 18 and 65 years of age, Being literate and verbally communicative, Being clinically stable (not exhibiting symptoms of acute psychosis), Being registered with a Community Mental Health Center (CMHC) and receiving regular services, Being cognitively competent enough to participate in individual interviews during the research process, Being an individual currently receiving psychiatric treatment and taking medication, Agreeing to participate voluntarily in the study and signing a written informed consent form.
Exclusion criteria
* those who do not meet the inclusion criteria
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| pretest (6-week solution-focused approach before the intervention) | Baseline (1 week before intervention)] | 1\. Psychosocial Adjustment (PSSAS) Description: Measured with the Psychosocial Adjustment Scale (PSSAS), which assesses social relationships, daily life management, and coping with stress. Scores range from 0 to 180; higher scores indicate better psychosocial adjustment. Time Frame: Baseline (within 1 week before intervention) Unit of Measure: Total score (0-180) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| posttest (After the 6-week solution-focused approach intervention) | 6 weeks after baseline (post-intervention) | 1\. Psychosocial Adjustment Post-Intervention (PSSAS) Description: Psychosocial Adjustment Scale (PSSAS). Scores range from 0 to 180; higher scores indicate better psychosocial adjustment. Time Frame: 6 weeks after baseline (post-intervention) Unit of Measure: Total score (0-180) |
Countries
Turkey (Türkiye)
Contacts
Primary ContactFatih Şahin, dr
Outcome results
None listed